Skin or soft tissue tumor radiation therapy using minibeams
Part of Cancer, Skin clinical trials.
This study tests a new type of radiation therapy, called minibeam radiation, for skin or soft tissue tumors that have come back or spread. The goal is to see if this approach can help shrink tumors while possibly sparing healthy tissue, and it's designed for people who may benefit from palliative treatment to relieve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed diagnosis of cancer that has spread to or started in the skin or soft tissue, and your doctor feels radiation could help you.
- You must be expected to live at least 30 days and be able to attend follow-up visits for at least 30 days.
- If you're a woman who can become pregnant, you must have a negative pregnancy test within 28 days before starting.
- You must agree to have photos taken of your skin/lesions and to provide blood and tissue samples for research.
- You cannot have certain types of tumors that are known to respond well to standard radiation, and you must not have had certain targeted therapies or investigational drugs recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a radiation-emitting device (DaRT) to treat certain cancers on the skin, in the mouth, or in superficial soft tissues. You may qualify if you have a confirmed malignant tumor, enough body strength for treatment, and blood tests and pregnancy status that meet safety limits.
This trial tests a precise type of radiation that targets multiple tumor spots in a carefully planned way. It may help people with many metastatic (spread) solid tumors when standard treatments aren’t working or can’t be used.
This Phase 1/2 study tests an “Auger molecular therapy” treatment that uses targeted radiation on certain advanced cancers that have spread to the skin. It may help shrink or control skin tumors where the lesion size and location fit the treatment device.
This study tests whether adding a special type of radiation to standard palliative radiation helps reduce symptoms like pain, shortness of breath, or bleeding. It's for people with tumors that can't be removed and are large.
This study looks at how a planned form of palliative radiation therapy treats certain solid cancers that have spread outside the brain to larger soft-tissue areas. It may help shrink tumors and relieve symptoms, but it also asks you to meet specific safety and treatment-timing rules.
This study tests a very focused form of radiation for melanoma that has spread and has stopped responding to PD-1 (and sometimes CTLA-4) immunotherapy. It may help by shrinking progressing spots while keeping the immune treatment going.
Hear when a new Skin Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.